MANCUSO, MICHELANGELO
 Distribuzione geografica
Continente #
NA - Nord America 21.380
AS - Asia 9.451
EU - Europa 7.420
SA - Sud America 1.857
AF - Africa 485
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 11
Totale 40.645
Nazione #
US - Stati Uniti d'America 20.780
SG - Singapore 3.124
CN - Cina 2.651
IT - Italia 2.516
HK - Hong Kong 1.823
BR - Brasile 1.564
SE - Svezia 1.148
DE - Germania 1.053
BG - Bulgaria 689
VN - Vietnam 539
TR - Turchia 434
GB - Regno Unito 427
CA - Canada 417
RU - Federazione Russa 328
FI - Finlandia 288
UA - Ucraina 242
AT - Austria 194
CI - Costa d'Avorio 186
IN - India 172
FR - Francia 143
KR - Corea 111
MX - Messico 100
JP - Giappone 97
AR - Argentina 96
BD - Bangladesh 92
CH - Svizzera 91
SN - Senegal 62
NL - Olanda 59
NG - Nigeria 58
IQ - Iraq 56
BE - Belgio 46
ZA - Sudafrica 46
IL - Israele 45
ES - Italia 43
MA - Marocco 43
EC - Ecuador 42
PL - Polonia 41
ID - Indonesia 40
PK - Pakistan 36
CO - Colombia 34
VE - Venezuela 32
UZ - Uzbekistan 29
SA - Arabia Saudita 27
CL - Cile 25
NZ - Nuova Zelanda 23
KE - Kenya 20
EG - Egitto 19
UY - Uruguay 19
AU - Australia 18
AZ - Azerbaigian 18
PE - Perù 18
CZ - Repubblica Ceca 16
IR - Iran 16
PH - Filippine 15
NP - Nepal 14
DK - Danimarca 13
PA - Panama 13
AE - Emirati Arabi Uniti 12
IE - Irlanda 12
MY - Malesia 12
OM - Oman 12
PY - Paraguay 12
TN - Tunisia 12
BJ - Benin 11
BO - Bolivia 11
JM - Giamaica 11
RO - Romania 11
JO - Giordania 10
GR - Grecia 9
LT - Lituania 9
EU - Europa 8
KG - Kirghizistan 8
PT - Portogallo 8
AL - Albania 7
BB - Barbados 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
LB - Libano 7
NI - Nicaragua 7
TT - Trinidad e Tobago 7
BH - Bahrain 6
DZ - Algeria 6
HN - Honduras 6
TH - Thailandia 6
TW - Taiwan 6
ET - Etiopia 5
GE - Georgia 5
KZ - Kazakistan 5
PS - Palestinian Territory 5
AM - Armenia 4
GT - Guatemala 4
BA - Bosnia-Erzegovina 3
BS - Bahamas 3
CG - Congo 3
CU - Cuba 3
CY - Cipro 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
RS - Serbia 3
Totale 40.593
Città #
Woodbridge 2.446
Ashburn 2.198
Fairfield 1.953
Hong Kong 1.799
Singapore 1.717
Houston 1.558
Ann Arbor 1.441
Chandler 1.178
Dallas 1.151
Santa Clara 1.124
Seattle 870
Milan 691
Sofia 686
Wilmington 676
Shanghai 672
Cambridge 622
Beijing 598
Serra 584
New York 469
Boardman 348
Ottawa 331
Jacksonville 311
Los Angeles 304
Princeton 290
Lawrence 274
Izmir 260
Medford 246
Abidjan 186
Nanjing 183
Hefei 158
Florence 155
Vienna 150
Frankfurt am Main 143
Des Moines 131
Istanbul 130
Munich 124
São Paulo 122
Redondo Beach 112
Buffalo 105
Ho Chi Minh City 105
San Diego 104
Seoul 102
Dong Ket 96
Rome 94
London 93
Tokyo 86
Pisa 85
Nanchang 84
Bern 83
Columbus 82
The Dalles 77
Dearborn 71
Ogden 69
Council Bluffs 67
Dakar 62
Redwood City 62
Norwalk 59
Jüchen 58
Lagos 57
Turku 54
Kunming 53
Hanoi 52
Belo Horizonte 49
Bremen 49
San Jose 49
Rio de Janeiro 45
Hebei 44
Nuremberg 44
Fuzhou 43
Lancaster 42
Brussels 39
Chicago 37
Düsseldorf 37
Boulder 36
Changsha 35
Shenyang 35
Pune 33
Lappeenranta 32
Warsaw 32
Washington 31
Falls Church 30
San Francisco 29
Helsinki 28
Phoenix 28
Tashkent 28
Jiaxing 27
Stockholm 27
Toronto 27
Mexico City 25
Quanzhou 25
Orem 24
Casablanca 23
Curitiba 23
Dhaka 23
Guangzhou 23
Montreal 23
Quito 23
Brooklyn 22
Nürnberg 20
Tianjin 20
Totale 29.461
Nome #
IER-SICH Nomogram to Predict Symptomatic Intracerebral Hemorrhage After Thrombectomy for Stroke 258
Vascular Factors and Mitochondrial Dysfunction: a Central Role in the Pathogenesis of Alzheimer's Disease. 233
Autosomal dominant psychiatric disorders and mitochondrial DNA multiple deletions: report of a family 232
Endothelium and oxidative stress: The Pandora's Box of cerebral (and non-only) small vessel disease? 231
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 228
Metabolic myopathies: functional evaluation by different exercise testing approaches 224
Myopathic involvement and mitochondrial pathology in Kennedy disease and in other motor neuron diseases 224
Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? 220
Antimyoclonic effect of levetiracetam in MERRF syndrome 220
Oxidative stress in cerebral small vessel disease dizziness patients, basally and after polyphenol compound supplementation 218
Mitochondrial DNA-related disorders 217
Hereditary spastic paraparesis in adults. A clinical and genetic perspective from Tuscany 215
Mitochondria, cognitive impairment, and Alzheimer's disease. 213
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic amyotrophic lateral sclerosis 211
Tetracycline treatment in patients with progressive external ophthalmoplegia. 209
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 208
Oxidative stress treatment for clinical trials in neurodegenerative diseases. 206
An atypical presentation of sporadic adult-onset centronuclear myopathy 205
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 205
Is erythropoietin gene a modifier factor in amyotrophic lateral sclerosis? 203
Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease 201
Diagnostic Approach to Mitochondrial Disorders: the Need for a Reliable Biomarker 201
Antioxidant capacity and protein oxidation in cerebrospinal fluid of amyotrophic lateral sclerosis 199
A novel mitochondrial tRNA(Ile) point mutation associated with chronic progressive external ophthalmoplegia and hyperCKemia. 197
"Mitochondrial neuropathies": A survey from the large cohort of the Italian Network 197
Mitochondrial non-syndromic sensorineural hearing loss: a clinical, audiological and pathological study from Italy, and revision of the literature 196
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany 196
Psychiatric involvement in adult patients with mitochondrial disease. 195
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 195
Mitochondrial DNA haplogroups may influence Fabry disease phenotype 194
Pes cavus and hereditary neuropathies: when a relationship should be suspected. 193
Inflammatory myopathy in a patient with postural and kinetik tremor. 193
Gly482Ser PGC-1α gene polymorphism and exercise-related oxidative stress in amyotrophic lateral sclerosis patients 191
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome 191
Reply to P.M. Foye ( Letter ) 190
May "mitochondrial eve" and mitochondrial haplogroups play a role in neurodegeneration and Alzheimer's disease? 190
Mitochondria and neurodegeneration 189
DNMT3B promoter polymorphisms and risk of late onset Alzheimer's disease. 187
A mitochondrial tRNAPhe mutation causes MERRF syndrome [Sindrome MERRF associata a mutazione del tRNAPhe] 185
Mitochondrial DNA single deletion in a patient with postural tremor. 185
.Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? 185
Lack of association between the APEX1 Asp148Glu polymorphism and sporadic Amyotrophic Lateral Sclerosis 185
Cerebral sinus venous thrombosis: Clinical and pathogenetic perspectives from Tuscany 184
Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients 184
Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 183
Brain MRI in Monogenic Cerebral Small Vessel Diseases: A Practical Handbook 183
Novel spastin (SPG4) mutations in Italian patients with hereditary spastic paraplegia 182
The Role of Mitochondria in StemCell Biology 182
Effects of aerobic training on exercise-related oxidative stress in mitochondrial myopathies. 182
Coenzyme Q10, exercise lactate and CTG trinucleotide expansion in myotonic dystrophy 181
COX AND MITOCHONDRIAL F1F0-ATPASE (ATP SYNTHASE) ACTIVITIES IN PLATELETS AND BRAIN FROM PATIENTS WITH ALZHEIMER'S DISEASE 180
.Clinical features and pathogenesis of Alzheimer's disease: involvement of mitochondria and mitochondrial DNA. 180
Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. 179
Mitochondrial DNA sequence variation and neurodegeneration. 178
Mitochondrial dysfunction and Alzheimer's disease: new developments 177
Anticoagulation After Stroke in Patients With Atrial Fibrillation 177
Epilepsy and limb girdle muscular dystrophy type 2A: double trouble, serendipitous finding or new phenotype? 176
Mitochondrial peripheral benzodiazepine receptor in amyotrophic lateral sclerosis 176
Acute encephalopathy of the temporal lobes leading to m.3243A>G. When MELAS is not always MELAS 176
Epidemiology and cerebrovascular events related to cervical and intracranial arteries dissection: the experience of the city of Pisa 176
Electron transfer mediators and other metabolites and cofactors in the treatment of mitochondrial dysfunction 175
Nerve and muscle involvement in mitochondrial disorders: an electrophysiological study. 174
Iron-sensitive MR imaging of the primary motor cortex to differentiate hereditary spastic paraplegia from other motor neuron diseases 172
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations. 171
Assessment of endogenous DNA oxidative stress in mitochondrial encephalomyopathies. 170
Drugs and mitochondrial diseases: 40 queries and answers. 170
Aging with Cerebral Small Vessel Disease and Dizziness: The Importance of Undiagnosed Peripheral Vestibular Disorders 170
Amyotrophic Lateral Sclerosis and Oxidative Stress: a Double-Blind Therapeutic Trial After Curcumin Supplementation 168
Vertebrobasilar recording with contrast transcranial Doppler in right-to-left shunt diagnosis 168
Phenotypic heterogeneity of the 8344A>G mtDNA "MERRF" mutation. 167
Abnormal H-Tfam in a patient harboring a single mtDNA deletion. 166
No evidence for allelic association of serotonin 2A receptor and transporter gene polymorphisms with depression in Alzheimer disease 166
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 166
Coenzyme Q10 in neuromuscular and neurodegenerative disorders 165
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations 165
POLG1-related and other "mitochondrial Parkinsonisms": an overview. 165
Metabolic muscle adaptation to aerobic training in patients affected by mitochondrial myopathies. 165
Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. 164
Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study 164
Abnormal levels of human mitochondrial transcription factor A in skeletal muscle in mitochondrial encephalomyopathies. 163
MULTIPLE CRANIAL NERVE PALSIES IN TESTICULAR LYMPHOMA: REPORT OF A CASE 161
Common Genetic Conditions of Ischemic Stroke to Keep in Mind 161
Cardiac involvement in chronic progressive external ophthalmoplegia 159
H-MTTFA muscle levels in mitochondrial myopathies. 159
A new truncating MPZ mutation associated with a very mild CMT1 B phenotype 158
G41S SOD1 mutation: A common ancestor for six ALS Italian families with an aggressive phenotype 158
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. 158
Autonomic, functional, skeletal muscle, and cardiac abnormalities are associated with increased ergoreflex sensitivity in mitochondrial disease 157
DPP6 gene variability confers increased risk of developing sporadic amyotrophic lateral sclerosis in Italian patients. 157
Genetics of ischaemic stroke in young adults 155
A non-syndromic hearing loss caused by very low levels of the mtDNA A3243G mutation 155
Proximal Myopathy due to m.5835G>A Mutation in Mitochondrial MT-TY Gene 153
CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions 153
Myocardial damage in a mitochondrial myopathy patient with increased ergoreceptor sensitivity and sympatho-vagal imbalance 152
Redefining phenotypes associated with mitochondrial DNA single deletion 152
Psychiatric involvement in adult patients with mitochondrial disease. 151
Sudden bilateral hearing loss and sporadic mitochondrial DNA deletion. 151
Epidemiology of dystrophinopathies in North-West Tuscany: a molecular genetics-based revisitation. 151
Levetiracetam-responsive myoclonus in spinocerebellar ataxia type 15. 151
Neurohormonal modulation for treatment of cardiac involvement in dystrophinopathies and mitochondrial disease 151
Totale 18.308
Categoria #
all - tutte 118.193
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 118.193


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.236 0 0 0 0 0 0 121 203 214 174 183 341
2021/20222.959 55 197 68 185 561 382 89 169 139 76 250 788
2022/20233.788 445 482 248 330 454 448 35 295 720 25 269 37
2023/20243.196 353 307 349 210 434 542 129 96 47 195 189 345
2024/20259.791 32 351 93 578 938 949 1.014 566 925 1.209 1.027 2.109
2025/20266.353 674 1.344 1.315 926 1.104 966 24 0 0 0 0 0
Totale 41.151